Artiva Biotherapeutics logo

Artiva Biotherapeutics Share Price Today

(NASDAQ: ARTV)

Artiva Biotherapeutics share price is $4.49 & ₹390.49 as on 6 Mar 2025, 2.30 'hrs' IST

$4.49

0.1

(2.28%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Artiva Biotherapeutics share price in Dollar and Rupees. Guide to invest in Artiva Biotherapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Artiva Biotherapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Artiva Biotherapeutics share price movements

  • Today's Low: $4.16
    Today's High: $4.53

    Day's Volatility :8.17%

  • 52 Weeks Low: $3.37
    52 Weeks High: $17.31

    52 Weeks Volatility :80.53%

Artiva Biotherapeutics (ARTV) Returns

PeriodArtiva Biotherapeutics IncIndex (Russel 2000)
3 Months
-62.16%
0.0%
6 Months
-63.14%
0.0%
1 Year
-63.42%
0.0%
3 Years
-63.42%
-11.6%

Artiva Biotherapeutics (ARTV) Key Statistics

in dollars & INR

Previous Close
$4.39
Open
$4.4
Today's High
$4.53
Today's Low
$4.16
Market Capitalization
$106.6M
Today's Volume
$116.3K
52 Week High
$17.31
52 Week Low
$3.37
Revenue TTM
$2.6M
EBITDA
$-58.6M
Earnings Per Share (EPS)
$-2.79
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-44.21%

How to invest in Artiva Biotherapeutics Stock (ARTV) from India?

It is very easy for Indian residents to invest directly in Artiva Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Artiva Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Artiva Biotherapeutics or ARTV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Artiva Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Artiva Biotherapeutics shares which would translate to 0.194 fractional shares of Artiva Biotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Artiva Biotherapeutics, in just a few clicks!

Returns in Artiva Biotherapeutics (ARTV) for Indian investors in Rupees

The Artiva Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Artiva Biotherapeutics investment value today

Current value as on today

₹42,379

Returns

₹57,621

(-57.62%)

Returns from Artiva Biotherapeutics Stock

₹62,583 (-62.58%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Artiva Biotherapeutics (ARTV)

117%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Artiva Biotherapeutics Stock from India on INDmoney has increased by 117% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Artiva Biotherapeutics

Analyst Forecast on Artiva Biotherapeutics Stock (ARTV)

What analysts predicted

Upside of 367.71%

Target:

$21.00

Current:

$4.49

Insights on Artiva Biotherapeutics Stock (Ticker Symbol: ARTV)

  • Price Movement

    In the last 7 days, ARTV stock has moved up by 13.7%

Artiva Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Artiva Biotherapeutics is currently in a neutral trading position according to technical analysis indicators.

Artiva Biotherapeutics (ARTV) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Artiva Biotherapeutics Inc logo
-10.22%
-63.14%
-63.42%
-63.42%
-63.42%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Artiva Biotherapeutics Inc logo
NA
NA
NA
-5.08
-0.44
0.0
NA
8.28
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Artiva Biotherapeutics Inc logo
NA
$106.6M
-63.42%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Artiva Biotherapeutics

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate is AB-101, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, systemic lupus erythematosus, and B-cell-non-Hodgkin lymphoma. It also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 chimeric antigen receptor (CAR)-NK cell product candidate; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate. The company was incorporated in 2019 and is headquartered in San Diego, California.
Organization
Artiva Biotherapeutics
Employees
82
CEO
Dr. Fred Aslan M.D.
Industry
Miscellaneous

Management People of Artiva Biotherapeutics

NameTitle
Dr. Fred Aslan M.D.
President, CEO & Director
Dr. Peter Flynn Ph.D.
Co-Founder & Strategic Advisor
Ms. Jennifer Kinsbruner Bush Esq., J.D.
Executive VP, COO, Chief Legal Officer, Corporate Secretary & Compliance Officer
Mr. Christopher P. Horan
Chief Technical Operations Officer
Ms. Neha Krishnamohan
CFO & Executive VP of Corporate Development
Dr. Thorsten Graef M.D., Ph.D.
Chief Medical Officer
Dr. Heather Raymon Ph.D.
Senior Vice President of Research & Early Development
Dr. David Moriarty Ph.D.
Senior VP of Clinical Operations

Important FAQs about investing in ARTV Stock from India :

What is Artiva Biotherapeutics share price today?

Artiva Biotherapeutics share price today stands at $4.49, Open: $4.40 ; Previous Close: $4.39 ; High: $4.53 ; Low: $4.16 ; 52 Week High: $17.31 ; 52 Week Low: $3.37.

The stock opens at $4.40, after a previous close of $4.39. The stock reached a daily high of $4.53 and a low of $4.16, with a 52-week high of $17.31 and a 52-week low of $3.37.

Can Indians buy Artiva Biotherapeutics shares?

Yes, Indians can invest in the Artiva Biotherapeutics (ARTV) from India.

With INDmoney, you can buy Artiva Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Artiva Biotherapeutics at zero transaction cost.

How can I buy Artiva Biotherapeutics shares from India?

It is very easy to buy Artiva Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Artiva Biotherapeutics (ARTV) be purchased?

Yes, you can buy fractional shares of Artiva Biotherapeutics with INDmoney app.

What are the documents required to start investing in Artiva Biotherapeutics stocks?

To start investing in Artiva Biotherapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Artiva Biotherapeutics Stock (ARTV)?

Today’s highest price of Artiva Biotherapeutics (ARTV) is $4.53.

Today’s lowest price of Artiva Biotherapeutics (ARTV) is $4.16.

What is today's market capitalisation of Artiva Biotherapeutics?

Today's market capitalisation of Artiva Biotherapeutics ARTV is 106.6M

What is the 52 Week High and Low Range of Artiva Biotherapeutics Stock (ARTV)?

  • 52 Week High

    $17.31

  • 52 Week Low

    $3.37

What are the historical returns of Artiva Biotherapeutics (ARTV)?

  • 1 Month Returns

    -10.22%

  • 3 Months Returns

    -63.14%

  • 1 Year Returns

    -63.42%

  • 5 Years Returns

    -63.42%

Who is the Chief Executive Officer (CEO) of Artiva Biotherapeutics ?

Dr. Fred Aslan M.D. is the current Chief Executive Officer (CEO) of Artiva Biotherapeutics.